Announced Tue, 4 Aug · 13:58 IST
Morepen Labs Q1 FY27 Investor Presentation filed
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+33.6%1-day move
₹57.40
prior close
₹68.21
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+1.4+1.4+1.4+33.6+38.6+39.4+39.5+33.8+41.6————
Up moveDown movePending
AI summary
Morepen Labs Q1 FY27: Highest-ever revenue of Rs. 575 Cr, up 34% YoY. EBITDA jumped 207% to Rs. 87.7 Cr with margin improving from 6.65% to 15.25%. PAT surged 394% to Rs. 56.35 Cr. Exports grew 111%. API business up 31%, Devices up 19%. CDMO mandate of Rs. 825 Cr entered commercial supplies with Rs. 58 Cr dispatches. Capacity expansion roadmap from 600 KL to 1200 KL.
Likely market impact
Strong quarter with 3x EBITDA growth and margin expansion signals operating leverage, likely positive for stock sentiment.